Burkina Faso vs Togo: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Burkina Faso
66.0%
in 2025
Togo
58.0%
in 2025
Burkina Faso rank
7th
Togo rank
10th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Burkina Faso
- Togo
How they compare
Burkina Faso currently reports 66.0% against 58.0% in Togo, a difference of 8.0%.
That makes Burkina Faso's figure about 1.1 times Togo's.
The two have swapped places 1 time across 10 shared years of data; in 2016 it was Togo ahead.
Burkina Faso ranks 7th and Togo ranks 10th of 26 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.2% | 0.0% | 52.2% | Burkina Faso |
| 2020s | 68.0% | 37.7% | 30.3% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Burkina Faso or Togo?
- Burkina Faso, at 66.0% against 58.0% in Togo as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Burkina Faso and Togo?
- 8.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Togo?
- 10 years are reported by both, from 2016 to 2025.
- How do Burkina Faso and Togo rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Burkina Faso ranks 7th and Togo ranks 10th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.